A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies

被引:70
作者
Ghanbari-Movahed, Maryam [1 ,2 ]
Jackson, Gloria [3 ]
Farzaei, Mohammad Hosein [1 ]
Bishayee, Anupam [3 ]
机构
[1] Kermanshah Univ Med Sci, Med Technol Res Ctr, Hlth Technol Inst, Kermanshah, Iran
[2] Univ Guilan, Fac Sci, Dept Biol, Rasht, Iran
[3] Lake Erie Coll Osteopath Med, Bradenton, FL 34211 USA
关键词
citrus fruits; naringin; cancer; therapy; molecular mechanisms; prevention; ENDOTHELIAL GROWTH-FACTOR; PROSTATE-CANCER CELLS; EHRLICH ASCITES TUMOR; NATURAL-PRODUCTS; IN-VITRO; CITRUS FLAVONOIDS; DOWN-REGULATION; OVARIAN-CANCER; ANTICANCER ACTIVITIES; CASPASE-3; ACTIVATION;
D O I
10.3389/fphar.2021.639840
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Natural product-based cancer preventive and therapeutic entities, such as flavonoids and their derivatives, are shown to have a noticeable capability to suppress tumor formation and cancer cell growth. Naringin, a natural flavanone glycoside present in various plant species, has been indicated to modulate different signaling pathways and interact with numerous cell signaling molecules, which allows for an extensive variety of pharmacological actions, such as amelioration of inflammation, oxidative stress, metabolic syndromes, bone disorders, and cancer. The purpose of this systematic review is to present a critical and comprehensive assessment of the antitumor ability of naringin and associated molecular targets in various cancers. Methods: Studies were identified through systematic searches of Science Direct, PubMed, and Scopus as well as eligibility checks according to predefined selection criteria. Results: Eighty-seven studies were included in this systematic review. There was strong evidence for the association between treatment with naringin alone, or combined with other drugs and antitumor activity. Additionally, studies showed that naringin-metal complexes have greater anticancer effects compared to free naringin. It has been demonstrated that naringin employs multitargeted mechanisms to hamper cancer initiation, promotion, and progression through modulation of several dysregulated signaling cascades implicated in cell proliferation, autophagy, apoptosis, inflammation, angiogenesis, metastasis, and invasion. Conclusion: The results of our work show that naringin is a promising candidate for cancer prevention and treatment, and might offer substantial support for the clinical application of this phytocompound in the future. Nevertheless, further preclinical and clinical studies as well as drug delivery approaches are needed for designing novel formulations of naringin to realize the full potential of this flavonoid in cancer prevention and intervention.
引用
收藏
页数:25
相关论文
共 180 条
  • [61] Design and synthesis of mixed micellar system for enhanced anticancer efficacy of Paclitaxel through its co-delivery with Naringin
    Jabri, Tooba
    Imran, Muhammad
    Aziz, Aisha
    Rao, Komal
    Kawish, Muhammad
    Irfan, Muhammad
    Malik, Muhammad Imran
    Simjee, Shabana Usman
    Arfan, Muhammad
    Shah, Muhammad Raza
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (05) : 703 - 714
  • [62] Flavonoids and the CNS
    Jager, Anna K.
    Saaby, Lasse
    [J]. MOLECULES, 2011, 16 (02) : 1471 - 1485
  • [63] Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy
    Jayakumar, Thanasekaran
    Hsu, Chia-Yuan
    Khamrang, Themmila
    Hsia, Chih-Hsuan
    Hsia, Chih-Wei
    Manubolu, Manjunath
    Sheu, Joen-Rong
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06)
  • [64] Cancer statistics, 2002
    Jemal, A
    Thomas, A
    Murray, T
    Thun, M
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2002, 52 (01) : 23 - 47
  • [65] Epidemiology and treatment patterns of epithelial ovarian cancer
    Jessmon, Philip
    Boulanger, Talia
    Zhou, Wei
    Patwardhan, Pallavi
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (05) : 427 - 437
  • [66] Naringenin-induced apoptosis is attenuated by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human leukemia U937 cells
    Jin, Cheng-Yun
    Park, Cheol
    Lee, Jun-Hyuk
    Chung, Kyung Tae
    Kwon, Taeg Kyu
    Kim, Gi-Young
    Choi, Byung Tae
    Choi, Yung Hyun
    [J]. TOXICOLOGY IN VITRO, 2009, 23 (02) : 259 - 265
  • [67] Simultaneous determination of ginsenoside Rb1, naringin, ginsenoside Rb2 and oridonin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study after oral administration of Weifuchun tablet
    Jin, Yiran
    Tian, Tingting
    Ma, Yinghua
    Xu, Huijun
    Du, Yingfeng
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2015, 1000 : 112 - 119
  • [68] Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update
    Joshi, Ruthvika
    Kulkarni, Yogesh A.
    Wairkar, Sarika
    [J]. LIFE SCIENCES, 2018, 215 : 43 - 56
  • [69] Flavonoids, bioactive components of propolis, exhibit cytotoxic activity and induce cell cycle arrest and apoptosis in human breast cancer cells MDA-MB-231 and MCF-7-a comparative study
    Kabala-Dzik, Agata
    Rzepecka-Stojko, Anna
    Kubina, Robert
    Iriti, Marcello
    Wojtyczka, Robert D.
    Buszman, Ewa
    Stojko, Jerzy
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 2018, 64 (08) : 1 - 10
  • [70] Flavonoids as protectors against doxorubicin cardiotoxicity:: Role of iron chelation, antioxidant activity and inhibition of carbonyl reductase
    Kaiserova, Helena
    Simunek, Tomas
    van der Vijgh, Wim J. F.
    Bast, Aalt
    Kvasnickova, Eva
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (09): : 1065 - 1074